Label-free mitochondrial imaging distinguishes perturbed retinal-cell states
Source check: Source checked. Not independent scientific confirmation.
Finding: AutoMitoNetwork combined learned image segmentation and support vector classification to analyze label-free mitochondrial images from a human retinal-cell line. Across 62 control, 65 respiration-inhibited and 62 glycolysis-inhibited cells, the study measured treatment-associated network changes and distinguished subtler perturbed states using combined image features. Cell-level train/test separation supported the bounded in-vitro finding; this does not establish a new causal mechanism, disease diagnosis or patient benefit.
Technology: AutoMitoNetwork; ilastik; support vector machine
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- Ilastik learned segmentation enables feature extraction; PCA/LDA transform training features and linear SVM classifies cell-separated test sets. Newly measured treated-cell network states rather than software availability alone support admission.
- Test and result
- New in-vitro retinal-cell image measurements and cell-separated classification of perturbation-linked states.
- Limitation / still unknown
- Disease diagnostic performance, independent laboratory replication and new causal mechanisms remain unestablished.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://onlinelibrary.wiley.com/doi/full/10.1002/cyto.a.24889
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 21 Nov 2026. Review scope: Primary full article Methods, Results and limitations plus Europe PMC bibliographic metadata; indexed primary publisher full text..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.